| Item Type | Name |
|
Concept
|
Immunotherapy
|
|
Concept
|
Immunotherapy, Adoptive
|
|
Academic Article
|
GUCY2C-targeted cancer immunotherapy: past, present and future.
|
|
Academic Article
|
Epitope-targeted cytotoxic T cells mediate lineage-specific antitumor efficacy induced by the cancer mucosa antigen GUCY2C.
|
|
Academic Article
|
Immunotherapeutic strategies to target prognostic and predictive markers of cancer.
|
|
Academic Article
|
Advances in cancer immunotherapy.
|
|
Academic Article
|
Colorectal cancer immunotherapy.
|
|
Academic Article
|
Guanylyl cyclase C-induced immunotherapeutic responses opposing tumor metastases without autoimmunity.
|
|
Academic Article
|
Tumor radiation therapy creates therapeutic vaccine responses to the colorectal cancer antigen GUCY2C.
|
|
Academic Article
|
Selective antigen-specific CD4(+) T-cell, but not CD8(+) T- or B-cell, tolerance corrupts cancer immunotherapy.
|
|
Academic Article
|
GUCY2C lysosomotropic endocytosis delivers immunotoxin therapy to metastatic colorectal cancer.
|
|
Academic Article
|
Could targeting T-helper cells aid the development of effective cancer vaccines?
|
|
Academic Article
|
Challenges to chimeric antigen receptor (CAR)-T cell therapy for cancer.
|
|
Academic Article
|
Guanylate cyclase C as a target for prevention, detection, and therapy in colorectal cancer.
|
|
Academic Article
|
Preclinical Evaluation of a Replication-Deficient Recombinant Adenovirus Serotype 5 Vaccine Expressing Guanylate Cyclase C and the PADRE T-helper Epitope.
|
|
Academic Article
|
Prime-Boost Immunization Eliminates Metastatic Colorectal Cancer by Producing High-Avidity Effector CD8+ T Cells.
|
|
Academic Article
|
Immunotherapy regimens for metastatic colorectal carcinomas.
|
|
Academic Article
|
The Heat-Stable Enterotoxin Receptor, Guanylyl Cyclase C, as a Pharmacological Target in Colorectal Cancer Immunotherapy: A Bench-to-Bedside Current Report.
|
|
Academic Article
|
Human GUCY2C-Targeted Chimeric Antigen Receptor (CAR)-Expressing T Cells Eliminate Colorectal Cancer Metastases.
|
|
Academic Article
|
The swinging pendulum of cancer immunotherapy personalization.
|
|
Academic Article
|
Listeria monocytogenes as a Vector for Cancer Immunotherapy: Current Understanding and Progress.
|
|
Academic Article
|
Advances in Chimeric Antigen Receptor T-Cell Therapies for Solid Tumors.
|
|
Academic Article
|
Therapeutic targeting of gastrointestinal cancer stem cells.
|
|
Academic Article
|
Split tolerance permits safe Ad5-GUCY2C-PADRE vaccine-induced T-cell responses in colon cancer patients.
|
|
Academic Article
|
pH-Dependent Grafting of Cancer Cells with Antigenic Epitopes Promotes Selective Antibody-Mediated Cytotoxicity.
|
|
Academic Article
|
Talkin' Toxins: From Coley's to Modern Cancer Immunotherapy.
|
|
Academic Article
|
Chimeric Ad5.F35 vector evades anti-adenovirus serotype 5 neutralization opposing GUCY2C-targeted antitumor immunity.
|
|
Academic Article
|
Stem cells as therapeutic targets in colorectal cancer.
|
|
Academic Article
|
Guanylyl cyclase C as a biomarker for immunotherapies for the treatment of gastrointestinal malignancies.
|
|
Academic Article
|
Vaccines and immune checkpoint inhibitors: a promising combination strategy in gastrointestinal cancers.
|
|
Academic Article
|
The shifting paradigm of colorectal cancer treatment: a look into emerging cancer stem cell-directed therapeutics to lead the charge toward complete remission.
|
|
Academic Article
|
Guanylyl cyclase 2C (GUCY2C) in gastrointestinal cancers: recent innovations and therapeutic potential.
|
|
Academic Article
|
Cancer Vaccines and Immunotherapy for Tumor Prevention and Treatment.
|
|
Academic Article
|
Targeting gastrointestinal cancers with chimeric antigen receptor (CAR)-T cell therapy.
|
|
Academic Article
|
Immune checkpoint inhibitors in luminal gastrointestinal malignancies: going beyond MSI-H/dMMR, TMB?and PD-L1.
|
|
Academic Article
|
Chimeric adenoviral (Ad5.F35) and listeria vector prime-boost immunization is safe and effective for cancer immunotherapy.
|
|
Academic Article
|
The poorly immunogenic tumor microenvironment of pancreatic cancer: the impact of radiation therapy, and strategies targeting resistance.
|
|
Academic Article
|
CD5 deletion enhances the antitumor activity of adoptive T cell therapies.
|
|
Academic Article
|
CD8a Structural Domains Enhance GUCY2C CAR-T Cell Efficacy.
|
|
Academic Article
|
Cancer mucosa antigens as a novel immunotherapeutic class of tumor-associated antigen.
|